Table 4.
Baseline characteristics of the first 116 participants.
| n=116 | |
|---|---|
| Age, years (mean + SD) | 61 + 13.2 |
| Sex, female, n (%) | 57 (49) |
| Ancestry/Ethnicity, n (%) | |
| White | 77 (66.4) |
| Black | 25 (21.6) |
| Hispanic/Latino | 7 (6.0) |
| East Asian | 5 (4.3) |
| Other | 2 (1.7) |
| Tumor type, n (%) | |
| Colorectal | 51 (44) |
| Pancreas | 33 (28.4) |
| Appendix | 9 (7.7) |
| Gastric | 5 (4.3) |
| Small intestine | 5 (4.3) |
| Esophageal | 4 (3.4) |
| Other | 9 (7.7) |
| Treatment regimen, n (%) | |
| FOLFOX-based | 47 (40.5) |
| Capecitabine-based | 35 (30.2) |
| FOLFIRI-based | 27 (23.3) |
| Other | 7 (6) |